An L-RNA-based aquaretic agent that inhibits vasopressin in vivo.
about
Aptamer based surface enhanced Raman scattering detection of vasopressin using multilayer nanotube arrays.Label-free microfluidic characterization of temperature-dependent biomolecular interactionsThe effects of the anti-hepcidin Spiegelmer NOX-H94 on inflammation-induced anemia in cynomolgus monkeys.A novel CGRP-neutralizing Spiegelmer attenuates neurogenic plasma protein extravasationDirect optical detection of viral nucleoprotein binding to an anti-influenza aptamer.Integrated Microfluidic Aptasensor for Mass Spectrometric Detection of Vasopressin in Human Plasma Ultrafiltrate.Emerging drugs for acute and chronic heart failure: current and future developments.Targeting complement component 5a promotes vascular integrity and limits airway remodelingThe versatility of oligonucleotides as potential therapeutics.Biostable L-DNAzyme for Sensing of Metal Ions in Biological Systems.A novel C5a-neutralizing mirror-image (l-)aptamer prevents organ failure and improves survival in experimental sepsisThe chemical biology of aptamers.Surface-enhanced Raman spectroscopy based quantitative bioassay on aptamer-functionalized nanopillars using large-area Raman mappingExploring the role of chirality in nucleic acid recognition.Identification and characterization of a mirror-image oligonucleotide that binds and neutralizes sphingosine 1-phosphate, a central mediator of angiogenesis.Polyetheylenimine-polyplexes of Spiegelmer NOX-A50 directed against intracellular high mobility group protein A1 (HMGA1) reduce tumor growth in vivo.Mathematical Model for Biomolecular Quantification Using Large-Area Surface-Enhanced Raman Spectroscopy Mapping.Late onset of Ccl2 blockade with the Spiegelmer mNOX-E36-3'PEG prevents glomerulosclerosis and improves glomerular filtration rate in db/db mice.
P2860
Q33637245-BB26C175-9F53-46E0-A3AD-08A0CA828C59Q34018803-3DC2CE7A-9AAE-4F0A-934D-BCE62DBAF2B5Q34324354-C3745A3B-828A-4D74-8338-59B520FC47D1Q35693015-62F31948-2731-415D-8FFA-7E340505FF00Q36221343-DA0E1272-ED22-4C67-AA0B-F2BCAD5A8ED0Q36250256-13BE4148-5548-4073-8063-CAF540A57976Q36758585-B1C66630-214B-439D-B16F-7762E81A59DAQ36762599-F4A15070-776D-4D47-A648-C161AC1035A8Q36897394-C1FCBF2F-593E-4A06-8B7B-52EC0EAE68A0Q36966466-972AFDBA-0B56-449B-9F3D-A1DC55043CDFQ37393792-ABD673D3-E167-49C6-944F-954B5FED7169Q37423243-454F7DEE-6921-4CEB-8C0C-1C5B3F468BC2Q37561751-A83C2C8A-27D4-4EBE-824B-B6D6CE2E1895Q37853120-251A01E5-1755-4F46-8F8A-5E544C0892AEQ38307041-8EC1DD97-85B8-4388-8EC2-4C68DE9759D7Q38339945-EC36FE9F-25AC-4925-A3F2-6298F574182DQ39792379-0FCCB04F-4E85-4848-BD05-47D706DDBCE6Q41788971-C03E5F58-ACF5-45CB-83C3-631886746DD0
P2860
An L-RNA-based aquaretic agent that inhibits vasopressin in vivo.
description
2006 nî lūn-bûn
@nan
2006 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2006 թվականի մարտին հրատարակված գիտական հոդված
@hy
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
name
An L-RNA-based aquaretic agent that inhibits vasopressin in vivo.
@ast
An L-RNA-based aquaretic agent that inhibits vasopressin in vivo.
@en
An L-RNA-based aquaretic agent that inhibits vasopressin in vivo.
@nl
type
label
An L-RNA-based aquaretic agent that inhibits vasopressin in vivo.
@ast
An L-RNA-based aquaretic agent that inhibits vasopressin in vivo.
@en
An L-RNA-based aquaretic agent that inhibits vasopressin in vivo.
@nl
prefLabel
An L-RNA-based aquaretic agent that inhibits vasopressin in vivo.
@ast
An L-RNA-based aquaretic agent that inhibits vasopressin in vivo.
@en
An L-RNA-based aquaretic agent that inhibits vasopressin in vivo.
@nl
P2093
P2860
P356
P1476
An L-RNA-based aquaretic agent that inhibits vasopressin in vivo.
@en
P2093
Dirk Eulberg
Klaus Buchner
Stefan Vonhoff
Sven Klussmann
Werner G Purschke
P2860
P304
P356
10.1073/PNAS.0509663103
P407
P577
2006-03-17T00:00:00Z